Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
103 studies found for:    Open Studies | "Diabetic Retinopathy"
Show Display Options
Rank Status Study
21 Not yet recruiting Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema;   Diabetes Mellitus
Intervention: Genetic: Studied cohort
22 Unknown  Macular Tractional Retinoschisis in Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention:
23 Unknown  A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: CANAKINUMAB (ILARIS®)
24 Recruiting Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Intravitreal Aflibercept Injection (IAI)
25 Not yet recruiting 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide
26 Recruiting Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Intravitreal dexamethasone implant;   Procedure: Vitrectomy
27 Recruiting Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Condition: Proliferative Diabetic Retinopathy (PDR)
Interventions: Drug: Ranibizumab;   Procedure: Laser photocoagulation;   Procedure: Ranibizumab & laser photocoagulation
28 Recruiting The Effect of Hyperbaric Chamber Treatment on Patients With Diabetic Retinopathy
Condition: Does Hyperbaric Chaber Treatment Improve Diabetic Retinopathy
Intervention:
29 Recruiting Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy
Conditions: Non Proliferative Diabetic Retinopathy;   Proliferative Diabetic Retinopathy
Interventions: Drug: Folic Acid, vit B6 and B12;   Drug: Placebo
30 Recruiting Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.
Condition: High Risk Proliferative Diabetic Retinopathy
Interventions: Procedure: Panretinal Photocoagulation (PRP);   Drug: Intravitreous injection of ranibizumab
31 Unknown  Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
Conditions: Uveitis;   Diabetic Retinopathy;   Choroidal Neovascularization
Intervention: Drug: adalimumab
32 Unknown  A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
Condition: Diabetic Retinopathy
Intervention: Drug: Vitreosolve
33 Unknown  Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
Condition: Diabetic Retinopathy
Intervention: Drug: bevacizumab
34 Unknown  The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: Triamcinolone
35 Recruiting Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage
Conditions: Diabetic Retinopathy;   Vitreous Hemorrhage
Intervention: Drug: intravitreal ranibizumab injections
36 Unknown  Safety and Efficacy of Low-Fluence PRP for PDR
Condition: Proliferative Diabetic Retinopathy
Interventions: Device: Low-fluence PRP with 532nm green LASER;   Device: Full-Fluence PRP with 532nm LASER
37 Unknown  Retinal Laser by Multi-spot Photocoagulator and Driving Eligibility
Condition: Proliferative Diabetic Retinopathy
Intervention: Procedure: Pan retinal Photocoagulation
38 Unknown  Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs Lucentis
Condition: Proliferative Diabetic Retinopathy (PDR)
Intervention: Other: Injection of Avastin / Lucentis, sampling aqueous humour
39 Unknown  Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR
Condition: Severe Non-proliferative Diabetic Retinopathy
Interventions: Radiation: T-PRP;   Radiation: S-PRP
40 Unknown  Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment
Conditions: Non Proliferative Diabetic Retinopathy;   Proliferative Diabetic Retinopathy
Intervention: Procedure: PASCAL laser treatment

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years